Poland – Pharmaceutical products – DOSTARCZANIE LEKÓW WG 73 PAKIETÓW

The subject of the contract is the supply of 73 packages of drugs to the Contracting Authority's premises (Kraków, os. Złotej Jesieni 1), in accordance with the description and requirements set out in Annex 1 to this specification. 2. For cytotoxic drugs/monoclonal antibodies, the Contracting Authority requires the inclusion of the data required in the SWZ, in particular Annex 1 to the SWZ, regarding the density of solutions or the mass of excipients; for dry substances - the mass of the active substance and the mass of additives. 3. The validity period / warranty period of the subject of the contract must not be shorter than 12 months from the date of delivery, and for nutritional preparations – not shorter than 12 months, but not shorter than 6 months. Deliveries of products with a shorter validity period may be allowed in exceptional situations and each time the authorised representative of the Contracting Authority must give consent for this by email confirmation. 4. Only drugs listed on the NFZ reimbursement lists may be used in drug and chemotherapy programmes (the price of the drug must not exceed the funding limit set by the NFZ). 5. By specifying a form such as "tabl." in the Specification, the Contracting Authority means all types of tablets; "kaps." means all types of capsules etc.; in other cases the form is specified precisely: for example, "tabl. dojelitowa" means that only a dojelitowa tablet is allowed. 6. For drugs registered both as OTC and Rx, the Contracting Authority requires the Rx-registered drug to be offered. 7. For drugs packaged in drops, the Contracting Authority requires the quantity of drops in the offered volume of the unit package to be stated. 8. For drugs in the form of tablets or capsules, the Contracting Authority requires primary packaging in the form of blisters, if the medicinal product is available in this type of packaging. 9. By medicinal product constituting part of the subject of the contract, shall be understood as medicinal products within the meaning of the Pharmaceutical Law of 6 September 2001 (i.e. Journal of Laws of 2025, item 750, as amended). The offered medicinal product must be authorised for marketing in accordance with the provisions of Article 3 or Article 4(1) and (2) or Article 4a of the Pharmaceutical Law. 10. The special-purpose nutritional foodstuffs offered as part of the subject of the contract must meet adequate requirements and be authorised for marketing in accordance with the provisions of the Act of 25 August 2006 on Food and Feed Safety (i.e. Journal of Laws of 2023, item 1448, as amended) and executive acts, including the Regulation of the Minister of Health of 16 September 2010 on special-purpose nutritional foodstuffs (i.e. Journal of Laws of 2015, item 1026). 11. The Contracting Authority, in the implementation of this contract in the part concerning the transport of products to the Contracting Authority's premises, allows the participation of subcontractors with the appropriate authorisations. 12. The remaining conditions of the contract are specified in the draft contract, which is Annex 3 to the Specification. 13. Delivery will take place successively over a period of 12 months from the date of signing the contract (applies to packages 1-10; 12-73), 24 months (applies to package 11), according to written orders sent by email by a Hospital Pharmacy employee. 14. Contract completion deadline - no longer than 3 working days from the date of order placement. 15. Possibility of urgent deliveries in the shortest agreed time with the Head of the Hospital Pharmacy, but not longer than within 24 hours from the date of order placement by email. 16. Deliveries, including the delivery and unloading of the medicinal product, will take place to the warehouse of the Contracting Authority's Hospital Pharmacy. The medicinal product will be accepted by a person authorised by the Head of the Hospital Pharmacy. The employee at the time of accepting the medicinal product will be obliged to check whether the delivery is in accordance with the quantity and quality with the attached documents and the contract. 17. The medicinal product will be delivered to the Contracting Authority in accordance with the conditions specified in the Regulation of the Minister of Health of 13 March 2015 on the requirements of Good Distribution Practice (Journal of Laws of 2015, item 381) (appropriate temperature documented by a temperature indicator). 18. In the event of the contract being performed in the part concerning transport using a subcontractor, the Contractor is responsible for the actions, omissions and negligence of the subcontractor as for his own actions, omissions and negligence, including compliance by the subcontractor with the requirement specified in paragraph 5.